CL
ARRY

CSS LLC’s Array Biopharma Inc ARRY Stock Holding History

CSS LLC’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-67,000
Closed -$3.1M – 890
2019
Q2 		$3.1M Sell
67,000
-18,500
-22% -$519K 0.18% 105
2019
Q1 		$2.09M Buy
85,500
+53,700
+169% +$1.12M 0.13% 122
2018
Q4 		$452K Hold
31,800
– – 0.03% 299
2018
Q3 		$484K Buy
31,800
+20,000
+169% +$306K 0.02% 307
2018
Q2 		$198K Hold
11,800
– – 0.01% 414
2018
Q1 		$193K Sell
11,800
-38,200
-76% -$612K 0.01% 418
2017
Q4 		$640K Sell
50,000
-99,600
-67% -$1.13M 0.03% 308
2017
Q3 		$1.84M Buy
+149,600
New +$1.39M 0.09% 163
2016
Q3 		– Sell
-18,700
Closed -$67K – 817
2016
Q2 		$67K Sell
18,700
-21,300
-53% -$69.4K ﹤0.01% 652
2016
Q1 		$118K Buy
40,000
+20,000
+100% +$59.9K 0.01% 585
2015
Q4 		$84K Buy
+20,000
New +$91.3K 0.01% 636

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

CSS LLC's ARRY Position: Q3 2019 in Review

CSS LLC sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 900 shares — an estimated $42K sold.

CSS LLC first reported a position in ARRY in Q4 2017 and held it in 2 quarters. The position peaked at $65K in Q4 2017. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • CSS LLC reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • CSS LLC sold 900 Array Biopharma Inc shares in Q3 2019, an estimated $42K.
  • CSS LLC first reported a position in Array Biopharma Inc in Q4 2017 and held it in 2 quarters.
  • CSS LLC's Array Biopharma Inc position peaked at $65K in Q4 2017.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on CSS LLC's 13F filing for Q3 2019, filed 14 Nov 2019.